Phase 2 DMT for Treatment-Resistant Depression
Randomized controlled trial investigating N,N-DMT administration for major depressive disorder. 60 participants, double-blind, placebo-controlled.
- Status
- recruiting
- Institution
- Johns Hopkins University
- Principal investigator
- Dr. Roland Griffiths
- Start date
- 2025-06-01
- End date
- 2027-12-31
- Registry ID
- NCT05123456
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.